Harbinger Health
PrivateLast Round
Series B
Extension
Apr 14, 2026
Total Funding Raised
$290M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Harbinger Health is a biotechnology company that develops AI-enabled, blood-based multi-cancer detection tests designed to identify cancer at its earliest stages.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Harbinger Health Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Harbinger Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 14, 2026 | ||||
| Series B | Sep 28, 2023 | ||||
| Series A | Dec 7, 2021 |
Key People
Founding team and executive leadership
Harbinger Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B Extension, Series B |
| M&G Investments | Series B Extension, Series B |
| Partners Investment | Series B Extension, Series B |
| Flagship Pioneering | Series B Extension, Series A, Series B |
| M&G plc | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Models infer lung cancer progression from blood draw cfDNA methylation data.
- Apr 14, 2026
$100M round raised.
Harbinger Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Harbinger Health's valuation, stock price, and market status.